(Q33926449)

30 July 2017

1 reference

title

Interleukin 16: implications for CD4 functions and HIV-1 progression (English)

1 reference

30 July 2017

Center DM

1

1 reference

30 July 2017

Kornfeld H

series ordinal

2

1 reference

30 July 2017

Ryan TC

series ordinal

3

1 reference

30 July 2017

Cruikshank WW

series ordinal

4

1 reference

30 July 2017

publication date

1 June 2000

1 reference

30 July 2017

1 reference

30 July 2017

volume

21

1 reference

30 July 2017

issue

6

1 reference

30 July 2017

page(s)

273-280

1 reference

Molecular cloning, sequence, expression, and processing of the interleukin 16 precursor

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Processing and activation of pro-interleukin-16 by caspase-3

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Structure of interleukin 16 resembles a PDZ domain with an occluded peptide binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Molecular cloning and sequence analysis of interleukin 16 from nonhuman primates and from the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Neuronal interleukin-16 (NIL-16): a dual function PDZ domain protein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Molecular and functional analysis of a lymphocyte chemoattractant factor: association of biologic function with CD4 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Interleukin-16 (IL-16) inhibits human immunodeficiency virus replication in cells from infected subjects, and serum IL-16 levels drop with disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

GA-binding protein factors, in concert with the coactivator CREB binding protein/p300, control the induction of the interleukin 16 promoter in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

The CD4-associated tyrosine kinase p56lck is required for lymphocyte chemoattractant factor-induced T lymphocyte migration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Human CD4+ cells transfected with IL-16 cDNA are resistant to HIV-1 infection: inhibition of mRNA expression

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Identification of a CD4 domain required for interleukin-16 binding and lymphocyte activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Interaction of HIV gp120 and anti-CD4 antibodies with the CD4 molecule on human CD4+ T cells inhibits the binding activity of NF-AT, NF-kappa B and AP-1, three nuclear factors regulating interleukin-2 gene enhancer activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Signal transduction through the CD4 receptor involves the activation of the internal membrane tyrosine-protein kinase p56lck

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Lymphocyte activation by HIV-1 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Cutting edge: CD4 is not required for the functional activity of IL-16

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

CD4-mediated stimulation of human eosinophils: lymphocyte chemoattractant factor and other CD4-binding ligands elicit eosinophil migration

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

The T cell receptor as a multicomponent signalling machine: CD4/CD8 coreceptors and CD45 in T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Increased expression of interleukin-16 in bronchial mucosa of subjects with atopic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Change in circulating levels of the chemokines macrophage inflammatory proteins 1 alpha and 11 beta, RANTES, monocyte chemotactic protein-1 and interleukin-16 following treatment of severely immunodeficient HIV-infected individuals with indinavir

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Role of IL-16 in HIV replication

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Circulating interleukin-16 in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

HIV suppression by interleukin-16.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Interleukin 16 and its function as a CD4 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

Recombinant human IL-16 inhibits HIV-1 replication and protects against activation-induced cell death (AICD)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5699%2800%2901629-7

7 January 2021

10.1016/S0167-5699(00)01629-7

Identifiers

DOI

1 reference

30 July 2017

1 reference